Jan Willem van der Laan

Statistics

Publications

Citations

1.7K

H-Index

Active since

1976

Affiliations

National Institute for Public Health and the Environment(Current)

Medicines Evaluation Board

Pfizer (United States)

Federal Institute for Drugs and Medical Devices

Centre for Human Drug Research

Jan Willem van der Laan is an author at National Institute for Public Health and the Environment specializing in pharmacology, medicine, and toxicology.

ORCID

Publications per year

1976–2024

Publications

Release of outer membrane fragments from normally growing Escherichia coli

Dick Hoekstra, Jan Willem van der Laan, Loe de Leij et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 1976 · 266 citations · Full text

Life Sciences, Microbiology, Molecular Biology +13

DT‐n‐PROPYLACETATE AND GABA DEGRADATION. PREFERENTIAL INHIBITION OF SUCCINIC SEMIALDEHYDE DEHYDROGENASE AND INDIRECT INHIBITION OF GABA‐TRANSAMINASE

Jan Willem van der Laan, Th. de Boer, J. Brunivels · Journal of Neurochemistry · 1979 · 148 citations

Life Sciences, Biochemistry, Neurobiology +17

The Utility of Two Rodent Species in Carcinogenic Risk Assessment of Pharmaceuticals in Europe

J.P.J Van Oosterhout, Jan Willem van der Laan, Eric J. De Waal et al. · Regulatory Toxicology and Pharmacology · 1997 · 87 citations

Pharmacy, Toxicology, Comparative Toxicology +11

Approaches and considerations for the assessment of immunotoxicity for environmental chemicals: A workshop summary

Darrell R. Boverhof, Greg Ladics, Bob Luebke et al. · Regulatory Toxicology and Pharmacology · 2013 · 66 citations · Full text

Pharmacy, Environmental Sciences, Toxicology +17

The RETHINK project

Roy Forster, Gerd Bode, Lars Ellegaard et al. · Journal of Pharmacological and Toxicological Methods · 2010 · 61 citations

1–5 of 46